These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 36260144)

  • 21. Why do pathological stage IA lung adenocarcinomas vary from prognosis?: a clinicopathologic study of 176 patients with pathological stage IA lung adenocarcinoma based on the IASLC/ATS/ERS classification.
    Zhang J; Wu J; Tan Q; Zhu L; Gao W
    J Thorac Oncol; 2013 Sep; 8(9):1196-202. PubMed ID: 23945388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sublobectomy for stage IA1-2 invasive lung adenocarcinoma with consolidation tumor ratio ≤ 0.25.
    Qi YF; Qiu ZB; Zhang C; Fu R; Yang XW; Chu XP; Chen ZH; Yang XN; Wu YL; Zhong WZ
    Thorac Cancer; 2022 Nov; 13(22):3174-3182. PubMed ID: 36208139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Limited Resection Is Associated With a Higher Risk of Locoregional Recurrence than Lobectomy in Stage I Lung Adenocarcinoma With Tumor Spread Through Air Spaces.
    Kadota K; Kushida Y; Kagawa S; Ishikawa R; Ibuki E; Inoue K; Go T; Yokomise H; Ishii T; Kadowaki N; Haba R
    Am J Surg Pathol; 2019 Aug; 43(8):1033-1041. PubMed ID: 31107717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is there a difference in survival for IA1 and IA2 adenocarcinoma of the uterine cervix?
    Smith HO; Qualls CR; Romero AA; Webb JC; Dorin MH; Padilla LA; Key CR
    Gynecol Oncol; 2002 May; 85(2):229-41. PubMed ID: 11972381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of the new IASLC/ATS/ERS classification of clinical stage IA lung adenocarcinoma.
    Murakami S; Ito H; Tsubokawa N; Mimae T; Sasada S; Yoshiya T; Miyata Y; Yokose T; Okada M; Nakayama H
    Lung Cancer; 2015 Nov; 90(2):199-204. PubMed ID: 26341957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Segmentectomy vs Lobectomy for Clinical Stage IA Lung Adenocarcinoma With Spread Through Air Spaces.
    Kagimoto A; Tsutani Y; Kushitani K; Kai Y; Kambara T; Miyata Y; Takeshima Y; Okada M
    Ann Thorac Surg; 2021 Sep; 112(3):935-943. PubMed ID: 33144104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of 7th and 8th editions of the UICC/AJCC TNM staging for non-small cell lung cancer in a non-metastatic North American cohort undergoing primary radiation treatment.
    Koul R; Rathod S; Dubey A; Bashir B; Chowdhury A
    Lung Cancer; 2018 Sep; 123():116-120. PubMed ID: 30089581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does the histologic predominance of pathological stage IA lung adenocarcinoma influence the extent of resection?
    Ito H; Nakayama H; Murakami S; Yokose T; Katayama K; Miyata Y; Okada M
    Gen Thorac Cardiovasc Surg; 2017 Sep; 65(9):512-518. PubMed ID: 28593420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Multi-institutional Analysis of the Combined Effect of Micropapillary Component and Consolidation-to-Tumor Ratio >0.5 on the Prognosis of Pathological, Stage IA3, Lung Adenocarcinoma.
    Xu SJ; Tu JH; Chen H; Yan RH; Chen RQ; Chen C; You CX; Zhang ZF; Yu SB; Chen SC
    Ann Surg Oncol; 2023 Sep; 30(9):5843-5853. PubMed ID: 37219654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prognostic impact of lung adenocarcinoma predominance classification relating to pathological factors in lobectomy, the Japanese Joint Committee of Lung Cancer Registry Database in 2010.
    Ito H; Date H; Shintani Y; Miyaoka E; Nakanishi R; Kadokura M; Endo S; Chida M; Yoshino I; Suzuki H;
    BMC Cancer; 2022 Aug; 22(1):875. PubMed ID: 35948946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical usefulness of the 3-tier classification according to the proportion of morphological patterns for patients with pathological stage I invasive lung adenocarcinoma.
    Osawa J; Shimada Y; Maehara S; Hagiwara M; Kakihana M; Kajiwara N; Ohira T; Matsubayashi J; Ikeda N
    Gen Thorac Cardiovasc Surg; 2021 Jun; 69(6):943-949. PubMed ID: 33385289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimating the cure proportion of stage IA lung adenocarcinoma: a population-based study.
    Huang Z; Chen D; Hong Z; Kang M
    BMC Pulm Med; 2023 Oct; 23(1):417. PubMed ID: 37907906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Verification of the eighth edition of the UICC-TNM classification on surgically resected lung adenocarcinoma: Comparison with previous classification in a local center.
    Minato H; Katayanagi K; Kurumaya H; Tanaka N; Fujimori H; Tsunezuka Y; Kobayashi T
    Cancer Rep (Hoboken); 2022 Jan; 5(1):e1422. PubMed ID: 34169671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of tumor spread through air spaces in patients with stage IA part-solid lung adenocarcinoma after sublobar resection.
    Chae M; Jeon JH; Chung JH; Lee SY; Hwang WJ; Jung W; Hwang Y; Cho S; Kim K; Jheon S
    Lung Cancer; 2021 Feb; 152():21-26. PubMed ID: 33338924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lung cancer - major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.
    Rami-Porta R; Asamura H; Travis WD; Rusch VW
    CA Cancer J Clin; 2017 Mar; 67(2):138-155. PubMed ID: 28140453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Positive EGFR mutation status is a risk of recurrence in pN0-1 lung adenocarcinoma when combined with pathological stage and histological subtype: A retrospective multi-center analysis.
    Ito M; Miyata Y; Tsutani Y; Ito H; Nakayama H; Imai K; Ikeda N; Okada M
    Lung Cancer; 2020 Mar; 141():107-113. PubMed ID: 32035371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicting prognosis using a pathological tumor cell proportion in stage I lung adenocarcinoma.
    Jeon HW; Kim YD; Sim SB; Moon MH
    Thorac Cancer; 2022 May; 13(10):1525-1532. PubMed ID: 35419984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of the proposals of the international association for the study of lung cancer in the forthcoming edition of lung cancer staging system to predict long-term prognosis of operated patients.
    Rena O; Massera F; Robustellini M; Papalia E; Delfanti R; Lisi E; Pirondini E; Turello D; Casadio C
    Cancer J; 2010; 16(2):176-81. PubMed ID: 20404615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive factors of recurrence after resection of subsolid clinical stage IA lung adenocarcinoma.
    Im DJ; Lee SM; Han K; Park CH; Lee JW; Hwang SH; Seo JS; Kwon W; Lee KH; Hur J
    Thorac Cancer; 2021 Mar; 12(6):941-948. PubMed ID: 33554473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implication of total tumor size on the prognosis of patients with clinical stage IA lung adenocarcinomas appearing as part-solid nodules: Does only the solid portion size matter?
    Kim H; Goo JM; Suh YJ; Park CM; Kim YT
    Eur Radiol; 2019 Mar; 29(3):1586-1594. PubMed ID: 30132107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.